Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.

Auteurs : Giunta EF, Bregni G, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 372-377

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.

Auteurs : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali MA, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Cancer Treat Rev
Volume : 96
Pagina's : 102177

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.

Auteurs : Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P
Jaar : 2021
Journal : Cancer Treat Rev
Pagina's : 102208

Targeted agents in older patients with gastrointestinal cancers - An overview.

Auteurs : Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 1240-1252

Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient: a case report and short literature review.

Auteurs : Ledouble V, Sclafani F, Hendlisz A, Gomez Galdon M, Liberale G
Jaar : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pagina's : 343-345

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Auteurs : Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, DHondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A
Jaar : 2021
Journal : Cancer Med
Volume : 10
Pagina's : 4366-4374

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Auteurs : Wrona E, Potemski P, Sclafani F, Borowiec M
Jaar : 2021
Journal : Arch Immunol Ther Exp (Warsz)
Volume : 69
Pagina's : 2

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Auteurs : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Acta oncol (Stockholm)
Volume : 60
Pagina's : 549-553

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.

Auteurs : Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.

Auteurs : Fontana E, Nyamundanda G, Cunningham D, Tu D, Cheang MCU, Jonker DJ, Siu LL, Sclafani F, Eason K, Ragulan C, Bali MA, Hulkki-Wilson S, Loree JM, Waring PM, Giordano M, Lawrence P, Rodrigues DN, Begum R, Shapiro JD, Price TJ, Cremolini C, Starling N, Pietrantonio F, Trusolino L, OCallaghan CJ, Sadanandam A
Jaar : 2020
Journal : JCO Precis Oncol
Volume : 4

Fat density is a novel prognostic marker in patients with esophageal cancer.

Auteurs : Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C
Jaar : 2020
Journal : Clin Nutr ESPEN
Volume : 39
Pagina's : 124-130

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.

Auteurs : Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F
Jaar : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pagina's : 1438-1446

Treatment compliance in early-stage anal cancer.

Auteurs : Pretta A, Trevisi E, Bregni G, Deleporte A, Hendlisz A, Sclafani F
Jaar : 2020
Journal : Ann Oncol
Volume : 31
Pagina's : 1282-1284

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

Auteurs : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali MA, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Jaar : 2020
Journal : Cancer Treat Rev
Volume : 83
Pagina's : 101948

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.

Auteurs : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Jaar : 2020
Journal : Cancer Treat Rev
Volume : 82
Pagina's : 101930

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Auteurs : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Jaar : 2020
Journal : Cancer Lett
Volume : 469
Pagina's : 142-150

Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.

Auteurs : Anciaux M, Demetter P, de Wind R, Gomez Galdon M, Vande Velde S, Lens G, Craciun L, Deleruelle A, Larsimont D, Lenaerts T, Sclafani F, Deleporte A, Donckier V, Hendlisz A, Vandeputte C
Jaar : 2020
Journal : BMJ Open Gastroenterol
Volume : 7

MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.

Auteurs : Camera S, Deleporte A, Bregni G, Trevisi E, Pretta A, Telli TA, Polastro L, Gombos A, Kayumba A, Ameye L, Piccart-Gebhart M, Awada A, Sclafani F, Hendlisz A
Jaar : 2020
Journal : Clin Colorectal Cancer
Volume : 19
Pagina's : 311-318.e1

Editorial: Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.

Auteurs : Sclafani F, Hendlisz A
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 344-346

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.

Auteurs : Ladanie A, Schmitt AM, Speich B, Naudet F, Agarwal A, Pereira TV, Sclafani F, Herbrand AK, Briel M, Martin-Liberal J, Schmid T, Ewald H, Ioannidis JPA, Bucher HC, Kasenda B, Hemkens LG
Jaar : 2020
Journal : JAMA Netw Open
Volume : 3
Pagina's : e2024406